Terazosin Discontinued in New Zealand
USANZ has been informed by Pharmac that terazosin will be discontinued in New Zealand.
- PHARMAC has been unsuccessful in sourcing a long-term supply of terazosin 2 mg and 5 mg tablets.
- Prescribers will need to transition patients to an alternative funded agent.
- PHARMAC have sourced a limited supply of an unapproved brand of terazosin, Teva Terazosin (supplied under section 29 of the Medicines Act 1981).
- Teva Terazosin will be available in New Zealand early October 2020 and will assist in the transition to alternative funded agents.